Objective-To investigate whether during acute asthma episodes a decrease in blood eosinophil count could correlate with the severity of the disease. Design-Prospective study on paediatric asthmatic patients admitted for acute asthma exacerbation between January 1992 and August 1993. All patients were regularly followed up in an outpatient clinic and had had a complete clinical evaluation <1 month before admission. Setting-Pulmonary division of the G Gaslini paediatric research institute,
eosinophils/mm3, p<0'0003. The decrease in the eosinophil count was more pronounced in the infected patients than in the non-infected patients, but the difference was not statistically significant (p>0.05).
Similarly, transcutaneous arterial oxygen pressure (Pao2) values measured during acute asthma exacerbations tended to be lower in infected patients, without, however, reaching statistical significance: 8*6 (0.7) v 10*1 (0.9) kPa, p>0.05). The correlation between the decrease in blood eosinophil count and Pao2 during the acute asthma exacerbations was significant in all the patients (r2=0*235, p=0*022) and in the non-infected patients (r2=0.653, p=0-015), but not in infected patients. In this latter subgroup, a significant negative correlation was found between blood neutrophil counts during acute asthma exacerbations and Pao2 (r2=349, p=0026).
Conclusions-During acute asthma exacerbations in atopic patients without clinical evidence of infection, the decrease in blood eosinophil count correlates significantly with the decrease in Pao2, further supporting the role ofeosinophils in allergic asthma. Although the basic immunological defect in asthma is still unknown, continuing investigations are yielding insights into the pathogenic components of this disorder. 1-3 Bronchoalveolar lavage, bronchial biopsy, and in vitro studies have provided convincing evidence that mast cells, T lymphocytes, and eosinophils are important components of the inflammatory reaction in allergic as well as in non-allergic (intrinsic) asthma. [4] [5] [6] In this context, cytokines released by T cells (with the Th2 phenotype) and by mast cells, which include interleukin (IL)-3, IL-4, IL-5, IL-10, and granulocyte macrophage colony stimulating factor (GM-CSF),78 not only modulate the production of allergen specific IgE in the airways,9 but also regulate the maturation, recruitment, and activation of eosinophils.3 10 Experimental exposure of atopic subjects with asthma to allergen inhalation results not only in degranulation of mast cells, but also in increased numbers of activated T lymphocytes and in recruitment of eosinophils.11 12 Similarly, in exercise induced asthma, degranulation of mast cells is associated in some patients with migration of eosinophils in the airways.5 The role played by eosinophils in the pathogenesis of asthma has been debated for years. While these cells have been considered 'beneficial components' of the host reaction, able to suppress mediators of inflammation in immediate-type hypersensitivity reactions,13 there is increasing evidence that they have the potential to injure host tissue through the release of toxic oxygen radicals and cytotoxic proteins.3 10 14 15 In this context, the presence of eosinophils in the bronchial mucosa and in the airways has been found to be statistically correlated with damage to the airway epithelium, including loss of epithelial junction,16 and to bronchial hyperreactivity at baseline16 or after allergen challenge. '7 Current concepts recognise that airway eosinophilia is the result of the efflux of circulating peripheral blood eosinophils, responding to chemoattractants that drive the cells toward the bronchial structures.10 14
These chemotactic stimuli have marked effects even on eosinophil activation, converting normal eosinophils into hypodense or degranulated eosinophils, and releasing mediators and cytotoxic products. 10 1 Consistent with this hypothesis is the demonstration that, after allergen inhalation challenge, the increased eosinophilia observed in bronchial biopsies and in bronchoalveolar lavage1 1 during the acute asthma episode; p<0-01). However, no statistically significant differences were observed between the infected and the non-infected groups in: (a) total blood eosinophil count previously determined in a stable period; (b) total eosinophil count measured during the acute asthma episode; and (c) the blood eosinophil count decrease (p>005, each comparison) (fig 1) .
PaO2 VALUES DURING ACUTE ASTHMA EPISODES
The non-invasive measurement of blood gases at the bedside by transcutaneous oximetry showed that the mean Pao2 value during the acute asthma episodes was 9-2 (0.6) kPa when evaluating all the patients together. Pao2 values tended to be lower in the infected group than in the non-infected group, at 8-6 (0 7) kPa and 10 1 (0.9) kPa, respectively) but the differences were not significant (p=0 296) 12 In addition, most of these products also have marked effects on cell activation, converting normal eosinophils into hypodense (or degranulated) eosinophils, which release granule associated proteins, proinflammatory substances, and cytotoxic molecules. [10] [11] [12] [13] [14] The best characterised mechanisms for eosinophil recruitmnent are chemotactic factors released after IgE dependent mast cell activation,7 8 lunl eosi ture diffi way a they may have been recruited to the lung, following the release of chemotactic factors by cells present in the airways. This hypothesis is in keeping with studies showing a fall in blood eosinophil counts'9 and bronchoalveolar lavage eosinophilia5 6 33 after allergen inhalation challenge. The causes of hypoxaemia in asthma are multiple, including bronchospasm, mucosal oedema, inflammatory changes of the airways, increased mucus secretion, and endoluminal mucus plug formation; the resulting decrease in alveolar Pao2 triggers vasoconstriction reflexes that often are responsible for ventilation/perfusion mismatching. In addition, because of the small diameter of the airways and the absence of collateral ventilation, atelectasis is frequent in young children during acute bronchospastic episodes.34 The eosinophils can play an important role in several of the mechanisms involved in the pathogenesis of bronchial asthma, through the release of powerful mediators with spasmogenic, proinflammatory, and prosecretory effects.14 [35] [36] [37] [38] The involvement of eosinophils in inducing morphological and functional changes in the airways in acute asthma is confirmed by the demonstration -provided by the present study -of a significant link between a fall in circulating eosinophil numbers and arterial hypoxaemia, particularly in atopic patients without clinical laboratory signs of infection. Interestingly, in patients with positive inflammatory signs, we found that Pao2 values correlated with blood neutrophilia rather than with blood eosinophil count dectease, suggesting that in different clinical settings other mechanisms, mediators, and cells might be involved in the functional damage to the respiratory system.
